His comments followed the grant of a licence by the UK's Human Tissue Authority, which allows the company import, export, process, store and distribute for treatment umbilical cord blood and tissue.
What in practice this official sanction does is allow the group, under its brand name BabyCells, to offer umbilical cord blood and tissue storage services to clients in the UK and Europe.
The company said the BabyCells service will be charged at around £2,000 per sample for one year's storage, with recurring storage revenues priced at £50-£75 a year thereafter.
Clients will be offered one year's stem cell insurance cover provided by the firm’s CellPlan division,” said CEO Andrade.
“This licence enables us to leverage further our significant industry contacts and market presence to position our state-of-the-art facility in Manchester as a leading stem cell storage bank.
“The group is now positioned to focus on revenue generation from all three of our divisions."